Menaquinone is one of the essential components of the electron transport chain in many pathogens and consequently enzymes in its biosynthesis pathway are potential drug targets for the development of novel antibacterial agents. Few years ago, Li et al.1 identified several 1,4-benzoxazine-2-one derivatives, targeting MenB (1,4-dihydroxy-2-naphtoyl-CoA synthase), endowed with high antibacterial activity against Mycobacteria tuberculosis H37Rv with MIC values of 0.6 μg/ml. By these assumptions, we designed and synthesized some analogous compounds in order to investigate the SAR and to discover new potent antimycobacterial derivatives. First of all, we tried to check the activity of several benzoxazine-3-one isosters and, in our case, the derivative showed low antimycobacterial activity (32->64 μg/ml) contradicting the bioisosterism principle. Then, we tried to modify the substituents on the original 1,4-benzoxazin-2-one core and we found some interesting data that will be presented. Moreover, we synthesized some 2-(arylamino)-4-oxobut-2-enoate derivatives as analogues of O-Succinyllbenzoate (OSB), a precursor in the menaquinone biosynthetic pathway. Details on antitubercular activity will be presented.

Antimycobacterial activity of new 1,4-Benzoxazine-2-one derivatives and its 2-(arylamino)-4-oxobut-2-enoate, ring-open analogues.

Daniele Zampieri
Writing – Original Draft Preparation
;
Marco Bernecich
Membro del Collaboration Group
;
Maria Grazia Mamolo
Membro del Collaboration Group
;
2017-01-01

Abstract

Menaquinone is one of the essential components of the electron transport chain in many pathogens and consequently enzymes in its biosynthesis pathway are potential drug targets for the development of novel antibacterial agents. Few years ago, Li et al.1 identified several 1,4-benzoxazine-2-one derivatives, targeting MenB (1,4-dihydroxy-2-naphtoyl-CoA synthase), endowed with high antibacterial activity against Mycobacteria tuberculosis H37Rv with MIC values of 0.6 μg/ml. By these assumptions, we designed and synthesized some analogous compounds in order to investigate the SAR and to discover new potent antimycobacterial derivatives. First of all, we tried to check the activity of several benzoxazine-3-one isosters and, in our case, the derivative showed low antimycobacterial activity (32->64 μg/ml) contradicting the bioisosterism principle. Then, we tried to modify the substituents on the original 1,4-benzoxazin-2-one core and we found some interesting data that will be presented. Moreover, we synthesized some 2-(arylamino)-4-oxobut-2-enoate derivatives as analogues of O-Succinyllbenzoate (OSB), a precursor in the menaquinone biosynthetic pathway. Details on antitubercular activity will be presented.
2017
http://www.mdpi.com/2504-3900/1/6
File in questo prodotto:
File Dimensione Formato  
proceedings-01-00209.pdf

accesso aperto

Descrizione: Paper proceeding
Tipologia: Documento in Versione Editoriale
Licenza: Creative commons
Dimensione 149.41 kB
Formato Adobe PDF
149.41 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/2917368
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact